Holen Sie sich die Stockscreener-App
1.64
5.81%
0.09
Handel nachbörslich:
1.65
0.01
+0.61%
Schlusskurs vom Vortag:
$1.55
Offen:
$1.57
24-Stunden-Volumen:
50.28M
Relative Volume:
4.20
Marktkapitalisierung:
$336.44M
Einnahmen:
$211.87M
Nettoeinkommen (Verlust:
$-551.61M
KGV:
-0.2403
EPS:
-6.8241
Netto-Cashflow:
$-140.45M
1W Leistung:
+56.19%
1M Leistung:
+45.13%
6M Leistung:
-13.23%
1J Leistung:
-75.88%
1-Tages-Spanne:
$1.55
$1.68
1-Wochen-Bereich:
$1.04
$1.805
52-Wochen-Spanne:
$0.77
$7.21
Canopy Growth Corporation Stock (CGC) Company Profile
Firmenname
Canopy Growth Corporation
Sektor
Telefon
855-558-9333
Adresse
1 Hershey Drive, Smiths Falls, ON
Vergleichen Sie CGC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.64 | 371.77M | 211.87M | -551.61M | -140.45M | -6.8241 |
|
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.96B | 957.25M | 5.31B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.26B | 1.98B | 0 | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-04 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-11-02 | Eingeleitet | Bernstein | Underperform |
| 2022-10-26 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-03-22 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-12-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-12-20 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-12-07 | Eingeleitet | Wells Fargo | Underweight |
| 2021-11-18 | Eingeleitet | Barclays | Equal Weight |
| 2021-11-08 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-11-08 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-11-08 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-10-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-08-12 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-06-02 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2021-05-25 | Hochstufung | MKM Partners | Neutral → Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-24 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-02-10 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-02-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-02-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-04 | Hochstufung | CFRA | Buy → Strong Buy |
| 2020-06-01 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-06-01 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-06-01 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2020-06-01 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-01 | Herabstufung | Stifel | Buy → Sell |
| 2020-05-22 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-04-16 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-01-28 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-12-12 | Bestätigt | Cantor Fitzgerald | Neutral |
| 2019-11-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-15 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-14 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2019-10-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2019-09-27 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-09-18 | Eingeleitet | Oppenheimer | Perform |
| 2019-08-26 | Hochstufung | Seaport Global Securities | Neutral → Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Canopy Growth Corporation Aktie (CGC) Neueste Nachrichten
Canopy Growth Stock Surge: Timing for Buying? - StocksToTrade
Promising Cannabis Stocks To Add to Your WatchlistAugust 13th - MarketBeat
Canopy Growth’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification - Benzinga
Promising Cannabis Stocks To Keep An Eye OnAugust 12th - MarketBeat
Explainer: How US marijuana reclassification could help cannabis companies - Reuters
Canopy Growth launches 7ACRES in Australia - MMJDaily
The Canopy, TerrAscend, and Village Farms Earnings Breakdown - The Dales Report
Canopy Growth Corporation (NASDAQ:CGC) Q1 2026 Earnings Call Transcript - Insider Monkey
Canopy Growth, Silver North Resources, Vonovia – Clear signals | 2025-08-12 | Investing News - Stockhouse
Canopy Growth Soars 12.03% on Trump's Marijuana Rescheduling Consideration - AInvest
Tilray Surges 14% After Hours On Trump Cannabis Reclassification - Benzinga
Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling (CRON) - Seeking Alpha
Canopy Growth Q1 Revenue Jumps on Strong Cannabis Sales - Tobacco Reporter
Canopy Growth Rallies On News Of Possible Rescheduling From Trump - Seeking Alpha
Pot Stocks Soar As Trump Considers Drug Reclassification - FA Mag
Pot stocks jump as Trump signals possible reclassification - MarketScreener
Pot Stocks Soar as Trump Considers Drug Reclassification - Bloomberg
Cannabis stocks rally as Trump mulls marijuana rescheduling within weeks (TLRY:NASDAQ) - Seeking Alpha
Canopy Growth Boosts European Market Position Amid Donald Trump’s Cannabis Reforms - timothysykes.com
While Investors Chase Monday's Tilray, Canopy And Aurora Rally, A Potential Federal Shift Could Redefine Cannabis Growth Fundamentals - Benzinga
Cannabis Stocks Rally as Trump Mulls Marijuana Reclassification - MSN
Canopy Growth’s Strategic Blowout: Challenges & Opportunities - StocksToTrade
Pot stocks soar as Trump considers marijuana reclassification - Investing.com
Pot stocks soar as Trump considers marijuana reclassification By Investing.com - Investing.com Canada
Will Canopy Growth Corporation’s Stock Momentum Persist? - timothysykes.com
Will Canopy Growth Corporation benefit from rising consumer demandHigh Profit Stock Recommendations - news-j.co.kr
Canopy Growth Soars 22.4% on Revenue Surge, Trump Policy Hints - AInvest
Canopy Growth Corporation (CGC) Growth Accelerates U.S. Expansion with Major Acquisitions - MSN
Canopy Growth posts Q1 beat thanks to strong cannabis sales - MSN
Canopy Growth Surges 19%—Uncovering the Hidden Catalyst - AInvest
Canopy Growth Appoints Margaret Shan Atkins to Board - The Globe and Mail
Canopy Growth Reports Strong Cannabis Revenue Growth - TipRanks
Canopy Growth 2026 Q1 Earnings Significant Loss Reduction - AInvest
Canopy Growth shares fall 1.60% after-hours following Q1 earnings report. - AInvest
European Equity Fund, Inc. shares rise 1.52% after-hours following recent financial results from Canopy Growth and Surrozen. - AInvest
Canopy Growth ($CGC) Inflated BioSteel Financials and Concealed Control Failures Case - TradingView
Canopy Growth (CGC.O) Surges 24.8% — What's Behind the Sharp Intraday Move? - AInvest
Canopy sees increase in revenue in Q1 2026, decrease in losses - StratCann
Stocks in play: Canopy Growth Corporation - The Globe and Mail
Can Cannabis Stocks Reverse Their Prolonged Downtrend? - The Globe and Mail
Earnings call transcript: Canopy Growth sees revenue rise in Q1 2025 - Investing.com
Canopy Growth tops Q1 estimates on strong Canadian adult-use sales - Proactive financial news
Canopy Growth (CGC.O) Surges 11%—What’s Behind the Sudden Move? - AInvest
Why Is Canopy Growth Stock Climbing Friday?Canopy Growth (NASDAQ:CGC) - Benzinga
Canopy Growth stock gains on cannabis-led Q1 beat (CGC) - Seeking Alpha
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Canopy Growth Reports First Quarter Fiscal 2026 Financial Results; Cannabis Revenue Increased 24% Year-Over-Year - The Globe and Mail
Earnings Snapshot: Canopy Growth FQ1 reports revenue of C$88.75M, up +17.1% Y/Y - MSN
Canopy Growth in charts: FQ1 Canada cannabis net revenue up 28% Y/Y, Storz & Bickel -24.7% - MSN
Canopy Growth Higher in U.S. Trading as Q1 Loss Narrows, Revenue Advances - 富途牛牛
Finanzdaten der Canopy Growth Corporation-Aktie (CGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):